Trial
NCT02144831
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Alberta
Collaborators
—
Condition
Transient Ischemic Attacks
Intervention
anti-thrombotic treatment using Aspirin (ASA 75-325mg) and Clopidogrel (75mg)
Why stopped
Could not get study started
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-27